Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
A Novel Oral Therapy TTP399 Discovered to Treat Type 1 DiabetesPatients
vTv Therapeutics discovered TTP399 therapy for the treatment of patients with Type 1 diabetes. TTP399 is a novel, oral, investigational once-daily glucokinase activator. It is considered to be an adjunctive therapy to insulin for the treatment...
A Breakthrough Therapy Discovered for Polycythemia Vera (PV)
Rusfertide, a breakthrough therapy discovered for the treatment of patients with Polycythemia Vera (PV). Rusfertide reduces the erythrocytosis in those patients who do not require further treatment for thrombocytosis and/or leucocytosis...
Novel Therapy BXCL501 Developed for the Treatment of Dementia
BXCL501, a novel therapy developed for the acute treatment of agitation related with dementia. BXCL501 is an investigational orally dissolving thin film formulation of dexmedetomidine...
A Novel Therapy Discovered for the Treatment of Relapsed or Refractory Multiple Myeloma
Janssen discovered novel therapy, Teclistamab for the treatment of relapsed or refractory multiple myeloma. Teclistamab is an off-the-shelf, T-cell redirecting, bispecific antibody which targets both B-Cell Maturation Antigen (BCMA) and CD3 receptors...
Novel Therapy, Sotorasib, Discovered for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Amgen novel therapy Sotorasib discovered for the treatment of patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients with KRAS G12C Mutation. Sotorasib, an investigational small molecule that selectively and irreversibly targets KRASG12C, is developed for the treatment of advanced or metastatic NSCLC in patient population....
Novel HER2-Targeted Bispecific Antibody Zanidatamab Developed for Patients with Biliary Tract Cancer
Zanidatamab, a bispecific antibody developed for the treatment of patients with previously-treated HER2 gene-amplified Biliary Tract Cancer (BTC). Zanidatamab is built on Zymeworks’ Azymetric™ platform binding two non-overlapping epitopes of HER2 known asbiparatopic binding....
Novel Elecsys Growth Differentiation Factor-15 (GDF-15) Assay Discovered for Cancer Treatment
Elecsys® GDF-15 assay discovered as a Companion Diagnostic (CDx) for the treatment of cancer. It helps in finding patients suitable for innovative treatment addressing unintentional weight loss in cancer patients. Elecsys GDF-15 a quantitative serologic which uses the format of sandwich test...
Novel APL-106 (uproleselan) Discovered for the Treatment of Acute Myeloid Leukemia
Apollomics, Inc discovered novel APL-106 (uproleselan) for the treatment of relapsed/refractory Acute Myeloid Leukemia (AML) in China. AML is an aggressive...
Novel Cancer Immunotherapy Tiragolumab Discovered for the Treatment of Non-Small Cell Lung Cancer
Tiragolumab, a novel cancer immunotherapy discovered for the treatment of metastatic Non-small Cell Lung Cancer (NSCLC). Tiragolumab, is the first anti-TIGIT molecule introduced to bind with TIGIT, a protein receptor on immune cells. It functions as an immune amplifier, by improving the body’s immune response. By combining with TIGIT...
New Xolair® Treats Severe Chronic Rhinosinusitis with Nasal Polyps
Novartis has discovered a new Xolair® indication for the treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) for adults. Xolair® (omalizumab), is the first discovered treatment option for CRSwNP which specifically targets and blocks the growth...
